Search Within

Karthik Nath

  1. "2023"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (3)
  3. Review (3)
  4. Editorial (1)
Groups
  1. GME, Medicine (16)
  2. Graduate Medical Education (16)
  3. Center for Hematologic Malignancies (14)
  4. Department of Medicine (14)
  5. Hematologic Malignancies, Division of (14)
  6. Bone Marrow Transplant (11)

More Groups

People
  1. Gunjan Shah (9)
  2. Michael Scordo (8)
  3. Sergio Giralt (8)
  4. Sham Mailankody (8)
  5. Sean Devlin (7)
  6. Miguel-Angel Perales (6)

More People

Years
  1. 2023 (16)
Publications
  1. Blood (5)
  2. Clinical Lymphoma, Myeloma and Leukemia (3)
  3. American Journal of Hematology (1)
  4. Bone Marrow Transplantation (1)
  5. Clinical Pharmacology & Therapeutics (1)
  6. Expert Opinion on Drug Safety (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. Elsevier Inc. (4)
  3. Nature Publishing Group (4)
  4. Informa Healthcare (1)
  5. John Wiley & Sons, Inc. (1)
  6. Wiley Blackwell (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The role of chimeric antigen receptor T-cell therapy in the era of bispecific antibodies
    Review

    Nath, K.; Mailankody, S.; Usmani, S. Z.
    Hematology/Oncology Clinics of North America (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel (LISO‐CEL) versus standard of care (SOC) as second‐line therapy in large B‐cell lymphoma (TRANSFORM study): Subgroup analyses by prior therapy response
    Meeting Abstract

    Tobin, J. W.; Jurinovic, V.; Tsang, H.; Roos, D.; Tsang, R.; Macann, A.; Davis, S.; Christie, D.; Law, S.; Nath, K.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • GPRC5D as a novel immunotherapeutic target in multiple myeloma
    Editorial

    Nath, K.; Costa, B. A.; Mailankody, S.
    Nature Reviews Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma
    Review

    Nath, K.; Wudhikarn, K.; Alarcon Tomas, A.; Perales, M. A.
    Expert Opinion on Drug Safety (2023)

    Fulltext@MSK | Save
  • Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
    Journal Article

    Van Oekelen, O.; Nath, K.; Mouhieddine, T. H.; Farzana, T.; Aleman, A.; Melnekoff, D. T.; Ghodke-Puranik, Y.; Shah, G. L.; Lesokhin, A.; Giralt, S.; more...
    Blood (2023)

    Fulltext@MSK | Save